NSPR
$0.41
Inspiremd
($.02)
(4.65%)
NSPR
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Tuesday
Nov 7
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when NSPR reports earnings?
Beat
Meet
Miss

Where is NSPR's stock price going from here?
Up
Flat
Down
Stock chart of NSPR
Analysts
Summary of analysts' recommendations for NSPR
Score
Grade
Pivots
Resistance
$0.52
$0.50
$0.45

$0.43

Support
$0.38
$0.36
$0.31
Tweet
Growth
Description
InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel.
Peers
StrykerAbbott LaboratoriesBoston ScientificBaxter InternationalIntegra LifeSciences HoldingsBecton, DickinsonC. R. Bard3MResMedWaters